Codes / ICD10CM / T38.895D

T38.895D Adverse effect of other hormones and synthetic substitutes, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of other hormones and synthetic substitutes, subsequent encounter

Summary

This condition represents an adverse effect resulting from exposure to hormones or their synthetic substitutes, classified as a subsequent encounter. It applies when the patient is receiving active treatment for the adverse effect during a later episode of care. The code is used when the specific hormone or substitute is not classified elsewhere and the event is not assigned to a more specific code.

Causes

The causes involve exposure to hormones, their synthetic analogues, or antagonists, which may result from therapeutic use, accidental ingestion, or incorrect dosing. Adverse effects can arise from the pharmacological properties of these agents, while unintended reactions may stem from individual sensitivity or drug interactions.

Risk Factors

  • Use of hormone therapies or antagonists for medical conditions
  • Polypharmacy involving hormonal agents
  • Incorrect dosing or administration
  • Individual sensitivity to hormonal substances
  • Renal or hepatic impairment affecting drug metabolism

Symptoms

Symptoms vary based on the specific hormone or agent involved and may include metabolic disturbances, endocrine imbalances, or organ-specific effects. Adverse reactions could manifest as hyper- or hypofunction of target systems, depending on the substance.

Diagnosis

Diagnosis requires a thorough patient history, including medication use, and clinical evaluation to identify the adverse effect. Laboratory tests or imaging may be used to assess organ function or metabolic status, depending on the suspected hormone or substitute involved.

Treatment Options

Treatment focuses on managing the adverse effect, which may include discontinuing the offending agent, supportive care, or specific interventions to address symptoms. The approach depends on the severity and nature of the reaction.

Prognosis and Follow-Up

Prognosis varies based on the severity of the adverse effect and the patient’s overall health. Follow-up care is typically required to monitor recovery and adjust treatment as needed, especially if the adverse effect impacts organ function or metabolic balance.

Complications

Complications may include prolonged organ dysfunction, metabolic imbalances, or persistent endocrine issues, depending on the hormone or substitute involved and the extent of the adverse effect.

Lifestyle & Prevention

Prevention involves careful medication management, including proper dosing, monitoring for interactions, and patient education on the risks of hormonal agents. Avoiding unnecessary exposure to unregulated hormonal products may also reduce risk.

When to Seek Professional Help

Seek medical attention if symptoms of an adverse effect develop after starting or changing hormonal therapy, or if existing symptoms worsen. Prompt evaluation is important for managing severe reactions.

Tips for Medical Coders

Document the encounter as a subsequent encounter (D) when the patient is receiving active treatment for the adverse effect. Ensure the code is used only when the specific hormone or substitute is not classified elsewhere and the event is not assigned to a more specific code. Verify that the encounter aligns with the definition of a subsequent encounter in clinical documentation.

Book a walkthrough

T38.895D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.